Progyny Non Currrent Assets Other vs Common Stock Total Equity Analysis
PGNY Stock | USD 28.09 0.54 1.96% |
Progyny financial indicator trend analysis is much more than just breaking down Progyny prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Progyny is a good investment. Please check the relationship between Progyny Non Currrent Assets Other and its Common Stock Total Equity accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Progyny. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. For more information on how to buy Progyny Stock please use our How to Invest in Progyny guide.
Non Currrent Assets Other vs Common Stock Total Equity
Non Currrent Assets Other vs Common Stock Total Equity Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Progyny Non Currrent Assets Other account and Common Stock Total Equity. At this time, the significance of the direction appears to have strong relationship.
The correlation between Progyny's Non Currrent Assets Other and Common Stock Total Equity is 0.79. Overlapping area represents the amount of variation of Non Currrent Assets Other that can explain the historical movement of Common Stock Total Equity in the same time period over historical financial statements of Progyny, assuming nothing else is changed. The correlation between historical values of Progyny's Non Currrent Assets Other and Common Stock Total Equity is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Non Currrent Assets Other of Progyny are associated (or correlated) with its Common Stock Total Equity. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Common Stock Total Equity has no effect on the direction of Non Currrent Assets Other i.e., Progyny's Non Currrent Assets Other and Common Stock Total Equity go up and down completely randomly.
Correlation Coefficient | 0.79 |
Relationship Direction | Positive |
Relationship Strength | Significant |
Non Currrent Assets Other
Assets that are not physical or tangible, expected to provide value for more than one year, and not easily converted into cash, such as long-term investments or patents.Common Stock Total Equity
The total value of common stock equity held by shareholders, representing their ownership interest in the company.Most indicators from Progyny's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Progyny current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Progyny. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. For more information on how to buy Progyny Stock please use our How to Invest in Progyny guide.At this time, Progyny's Tax Provision is fairly stable compared to the past year. Discontinued Operations is likely to rise to about 7 M in 2024, whereas Selling General Administrative is likely to drop slightly above 59 M in 2024.
2023 | 2024 (projected) | Discontinued Operations | 6.6M | 7.0M | Interest Income | 732.6K | 421.8K |
Progyny fundamental ratios Correlations
Click cells to compare fundamentals
Progyny Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Progyny fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 150.4M | 253.9M | 358.1M | 543.0M | 756.6M | 794.5M | |
Other Current Liab | 16.8M | 34.3M | 2.2M | 49.0M | 1.2M | 1.1M | |
Total Current Liabilities | 36.2M | 77.8M | 98.8M | 159.5M | 186.0M | 95.3M | |
Total Stockholder Equity | 114.3M | 166.9M | 251.8M | 377.0M | 553.4M | 581.1M | |
Net Tangible Assets | 100.0M | 153.9M | 239.3M | 365.0M | 419.7M | 440.7M | |
Property Plant And Equipment Net | 3.1M | 12.1M | 12.8M | 15.3M | 27.8M | 29.2M | |
Net Debt | (80.4M) | (62.0M) | (84.0M) | (112.4M) | (77.9M) | (81.8M) | |
Retained Earnings | (113.5M) | (68.2M) | (2.4M) | 27.9M | 90.0M | 94.5M | |
Accounts Payable | 19.4M | 43.5M | 61.4M | 109.3M | 125.4M | 131.7M | |
Cash | 80.4M | 70.3M | 91.4M | 120.1M | 97.3M | 73.0M | |
Non Current Assets Total | 18.0M | 63.7M | 99.5M | 109.1M | 116.2M | 69.4M | |
Non Currrent Assets Other | 652K | 573K | 2.9M | 4.0M | 3.4M | 1.9M | |
Other Assets | 652K | 8.2M | 74.2M | 81.9M | 94.2M | 98.9M | |
Cash And Short Term Investments | 80.4M | 109.3M | 119.4M | 189.3M | 371.1M | 389.6M | |
Net Receivables | 47.1M | 75.7M | 134.6M | 240.1M | 241.9M | 121.6M | |
Common Stock Shares Outstanding | 83.6M | 99.1M | 100.4M | 100.0M | 100.7M | 101.6M | |
Liabilities And Stockholders Equity | 150.4M | 253.9M | 358.1M | 543.0M | 756.6M | 794.5M | |
Non Current Liabilities Total | 19.4M | 9.2M | 7.4M | 6.5M | 17.2M | 10.4M | |
Capital Surpluse | 228.8M | 236.1M | 255.3M | 349.5M | 402.0M | 422.1M | |
Other Current Assets | 5.0M | 5.3M | 4.6M | 4.5M | 27.5M | 28.8M | |
Other Stockholder Equity | 227.7M | 235.1M | 254.3M | 348.5M | 460.6M | 242.6M | |
Total Liab | 36.2M | 87.0M | 106.2M | 166.0M | 203.2M | 102.6M | |
Net Invested Capital | 114.3M | 166.9M | 251.8M | 377.0M | 553.4M | 581.1M | |
Property Plant And Equipment Gross | 3.1M | 12.1M | 12.8M | 15.3M | 33.1M | 34.8M | |
Total Current Assets | 132.4M | 190.2M | 258.5M | 433.9M | 640.4M | 672.4M | |
Accumulated Other Comprehensive Income | (150.4M) | 1K | (93K) | 501K | 2.8M | 3.0M | |
Net Working Capital | 96.3M | 112.4M | 159.7M | 274.3M | 454.5M | 477.2M | |
Intangible Assets | 2.4M | 1.2M | 599K | 99K | 89.1K | 84.6K | |
Property Plant Equipment | 3.1M | 3.4M | 12.8M | 8.4M | 9.6M | 5.3M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Progyny offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Progyny's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Progyny Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Progyny Stock:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Progyny. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. For more information on how to buy Progyny Stock please use our How to Invest in Progyny guide.You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Complementary Tools for Progyny Stock analysis
When running Progyny's price analysis, check to measure Progyny's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Progyny is operating at the current time. Most of Progyny's value examination focuses on studying past and present price action to predict the probability of Progyny's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Progyny's price. Additionally, you may evaluate how the addition of Progyny to your portfolios can decrease your overall portfolio volatility.
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |
Is Progyny's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Progyny. If investors know Progyny will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Progyny listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.06) | Earnings Share 0.61 | Revenue Per Share 11.583 | Quarterly Revenue Growth 0.076 | Return On Assets 0.0569 |
The market value of Progyny is measured differently than its book value, which is the value of Progyny that is recorded on the company's balance sheet. Investors also form their own opinion of Progyny's value that differs from its market value or its book value, called intrinsic value, which is Progyny's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Progyny's market value can be influenced by many factors that don't directly affect Progyny's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Progyny's value and its price as these two are different measures arrived at by different means. Investors typically determine if Progyny is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Progyny's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.